Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Addressing equity in clinical trials

In this Mayo Clinic Q&A podcast video, Dr. Gerardo Colon-Otero and clinical trial participant Sonya Goins discuss equity in research and clinical trials.

AI reduces miss rate of precancerous polyps in colorectal cancer screening

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reports Mayo-led research team.

Mayo Clinic researchers load CAR-T cells with oncolytic virus to treat solid cancer tumors

Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.